Pinostrobin|CAS 75291-74-6|DC Chemicals

Cas No.:	75291-74-6
Chemical Name:	(±)-Pinostrobin
Synonyms:	4H-1-Benzopyran-4-one,2,3-dihydro-5-hydroxy-7-methoxy-2-phenyl-;7-METHOXYFLAVANONE;(+/-)-phoracantholid I;(+/-)-Phoracantholide;(+/-)-phoracantholide I;(+/-)-pinostrobin;10-Methyl-2-oxecanone;10-Methyloxacyclodecan-2-one;10-methyl-oxecan-2-one;2-Oxecanone, 10-methyl-;2-Oxecanone, 10-methyl-, (.+-.)-;5-hydroxy-6-methoxyflavanone (pinostrobin);5-hydroxy-7-methoxy-2-p;AC1LBYTY;AG-J-08296;CTK1J7068;dl-phoracantholide I;phoracantholide I;phorocantholide I;(RS)-2,3-Dihydro-5-hydroxy-7-methoxy-2-phenyl-4H-1-benzopyran-4-one;BCP09997;Chloroformic acidN-amyl ester;FT-0620476;(S)-2,3-Dihydro-5-hydroxy-7-methoxy-2-phenyl-4-benzopyrone;AKOS016009493;()-Pinostrobin;5-hydroxy-7-methoxy-2-phenylchroman-4-one;LMPK12140216;( inverted exclamation markA)-Pinostrobin;FT-0632188;ORJDDOBAOGKRJV-UHFFFAOYSA-N;5-Hydroxy-7-methoxyflavanone;CHEMBL210800;NS00074278;(2R)-5-hydroxy-7-methoxy-2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one;(+/-)-Pinostrobin, >=99.0% (TLC);SCHEMBL1485747;Pinostrobin;480-37-5;5-hydroxy-7-methoxy-2-phenyl-2,3-dihydrochromen-4-one;MFCD00017481;75291-74-6;2,3-Dihydro-5-hydroxy-7-methoxy-2-phenyl-4H-1-benzopyran-4-one;DB-051500
SMILES:	COC1=CC(=C2C(=O)CC(C3=CC=CC=C3)OC2=C1)O
Formula:	C₁₆H₁₄O₄
M.Wt:	270.27996
Purity:	98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.